Document Detail


Successful pregnancy after busulfan/cytoxan conditioning regimen for AML.
MedLine Citation:
PMID:  21694553     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The number of patients who have had successful pregnancies following hematopoietic stem cell transplant during childhood remains under investigation. As the number of survivors increase and enter adulthood, we continue to learn more about fertility in these patients. In this case report we report the case of a 27 year-old female who had a normal full term delivery 19 years following a myeloablative autologous transplant for relapsed acute myelogenous leukemia.
Authors:
Ami J Shah
Related Documents :
10390113 - Acog practice bulletin. medical management of tubal pregnancy. number 3, december 1998....
1916493 - Appropriateness of cholecystectomy in the united kingdom--a consensus panel approach.
14510343 - Thyroid function tests in pregnancy.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  33     ISSN:  1536-3678     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-22     Completed Date:  2011-09-01     Revised Date:  2011-10-06    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e180-1     Citation Subset:  IM    
Affiliation:
Division of Research Immunology/Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA. Ashah@chla.usc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Busulfan / therapeutic use*
Child
Cyclophosphamide / therapeutic use*
Female
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute / therapy*
Myeloablative Agonists / therapeutic use
Pregnancy
Pregnancy Outcome*
Recurrence
Time Factors
Transplantation Conditioning / methods*
Chemical
Reg. No./Substance:
0/Myeloablative Agonists; 50-18-0/Cyclophosphamide; 55-98-1/Busulfan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in in...
Next Document:  A retrospective study of malaria in pediatric oncology patients in Senegal.